908 related articles for article (PubMed ID: 26581499)
41. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Franke H; Illes P
Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
[TBL] [Abstract][Full Text] [Related]
42. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.
Melani A; Turchi D; Vannucchi MG; Cipriani S; Gianfriddo M; Pedata F
Neurochem Int; 2005 Nov; 47(6):442-8. PubMed ID: 16029911
[TBL] [Abstract][Full Text] [Related]
43. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
[TBL] [Abstract][Full Text] [Related]
44. P2X7 receptor expression after ischemia in the cerebral cortex of rats.
Franke H; Günther A; Grosche J; Schmidt R; Rossner S; Reinhardt R; Faber-Zuschratter H; Schneider D; Illes P
J Neuropathol Exp Neurol; 2004 Jul; 63(7):686-99. PubMed ID: 15290894
[TBL] [Abstract][Full Text] [Related]
45. Purines and pain mechanisms: recent developments.
Liu XJ; Salter MW
Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
[TBL] [Abstract][Full Text] [Related]
46. Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes.
Ciccarelli R; Di Iorio P; Ballerini P; Ambrosini G; Giuliani P; Tiboni GM; Caciagli F
J Neurosci Res; 1994 Dec; 39(5):556-66. PubMed ID: 7891391
[TBL] [Abstract][Full Text] [Related]
47. Smooth muscle and purinergic contraction of the human, rabbit, rat, and mouse testicular capsule.
Banks FC; Knight GE; Calvert RC; Turmaine M; Thompson CS; Mikhailidis DP; Morgan RJ; Burnstock G
Biol Reprod; 2006 Mar; 74(3):473-80. PubMed ID: 16280417
[TBL] [Abstract][Full Text] [Related]
48. Contribution of P2X purinergic receptor in cerebral ischemia injury.
Zhang WJ; Hu DX; Lin SJ; Fang XQ; Ye ZF
Brain Res Bull; 2022 Nov; 190():42-49. PubMed ID: 36113681
[TBL] [Abstract][Full Text] [Related]
49. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors.
Chen Y; Corriden R; Inoue Y; Yip L; Hashiguchi N; Zinkernagel A; Nizet V; Insel PA; Junger WG
Science; 2006 Dec; 314(5806):1792-5. PubMed ID: 17170310
[TBL] [Abstract][Full Text] [Related]
50. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
[TBL] [Abstract][Full Text] [Related]
51. Purines and neuroprotection.
Stone TW
Adv Exp Med Biol; 2002; 513():249-80. PubMed ID: 12575824
[TBL] [Abstract][Full Text] [Related]
52. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
53. Purines and neutrophil leukocytes.
Fredholm BB
Gen Pharmacol; 1997 Mar; 28(3):345-50. PubMed ID: 9068971
[TBL] [Abstract][Full Text] [Related]
54. Prenatal exposure to valproic acid induces alterations in the expression and activity of purinergic receptors in the embryonic rat brain.
Babiec L; Wilkaniec A; Adamczyk A
Folia Neuropathol; 2022; 60(4):390-402. PubMed ID: 36734381
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
[TBL] [Abstract][Full Text] [Related]
56. P2 receptors and neuronal injury.
Franke H; Krügel U; Illes P
Pflugers Arch; 2006 Aug; 452(5):622-44. PubMed ID: 16645849
[TBL] [Abstract][Full Text] [Related]
57. Role of Purinergic Signaling in Acupuncture Therapeutics.
Lv ZY; Yang YQ; Yin LM
Am J Chin Med; 2021; 49(3):645-659. PubMed ID: 33641652
[TBL] [Abstract][Full Text] [Related]
58. P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.
Woo SH; Trinh TN
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383710
[TBL] [Abstract][Full Text] [Related]
59. Purinergic signaling, DAMPs, and inflammation.
Di Virgilio F; Sarti AC; Coutinho-Silva R
Am J Physiol Cell Physiol; 2020 May; 318(5):C832-C835. PubMed ID: 32159362
[TBL] [Abstract][Full Text] [Related]
60. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
